ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,066.18
0.95%
Dow Jones
38,238.30
0.88%
US Dollar vs MXN
16.96385
0.12%
Brent Oil
83.62
0.10%
Bitcoin
59,135.23
1.54%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Molecular Templates Inc (MTEM)

  7. Molecular Templates Inc (MTEM) Noticias

MTEM Molecular Templates Inc

1.70
0.05 (3.03%)
Última actualización: 13:55:39
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Molecular Templates Inc MTEM NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.05 3.03% 1.70 13:55:39
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.64 1.55 1.72 1.65
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
09/4/202407:11GLOBEMolecular Templates Presents Interim Data from MT-6402 Phase..
29/3/202407:21GLOBEMolecular Templates, Inc. Reports Fourth Quarter 2023..
28/3/202407:11GLOBEMolecular Templates Announces $9.5 Million Private Placement..
04/3/202407:11GLOBEMolecular Templates, Inc. Provides Interim Update
14/2/202419:39EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202415:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202416:55GLOBEMolecular Templates to Present at Oppenheimer 34th Annual..
25/1/202416:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202415:04EDGAR2Form 8-K - Current report
13/11/202315:13EDGAR2Form 8-K - Current report
13/11/202315:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:11GLOBEMolecular Templates, Inc. Reports Third Quarter 2023..
02/11/202315:11GLOBEMolecular Templates Announces First Patient Dosed in Phase 1..
01/11/202315:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202315:12GLOBEMolecular Templates to Participate in Upcoming Investor..
31/10/202317:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202317:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202317:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202317:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202317:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202317:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/10/202315:12EDGAR2Form 8-K - Current report
06/10/202316:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
28/9/202316:01EDGAR2Form 8-K - Current report
28/9/202315:11GLOBEMolecular Templates Announces the Appointment of Dr...
12/9/202316:15EDGAR2Form ARS - Annual Report to Security Holders
12/9/202316:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/9/202316:08EDGAR2Form DEF 14A - Other definitive proxy statements
31/8/202317:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202315:11EDGAR2Form 8-K - Current report
11/8/202315:12EDGAR2Form 8-K - Current report
11/8/202310:22GLOBEMolecular Templates Announces 1-for-15 Reverse Stock Split
10/8/202308:01EDGAR2Form S-3 - Registration statement under Securities Act of..
10/8/202307:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202307:09EDGAR2Form 8-K - Current report
10/8/202307:08GLOBEMolecular Templates, Inc. Reports Second Quarter 2023..
02/8/202315:16EDGAR2Form 8-K - Current report
02/8/202315:11GLOBEMolecular Templates Announces Executive Leadership Changes
18/7/202310:56EDGAR2Form DEF 14A - Other definitive proxy statements
13/7/202311:48EDGAR2Form 8-K - Current report
13/7/202307:14GLOBEMolecular Templates Announces Up to $40 Million Private..
30/6/202315:31EDGAR2Form PRE 14A - Other preliminary proxy statements
16/6/202319:56GLOBEMolecular Templates Announces Debt Payoff and Restructuring
01/6/202306:57GLOBEMolecular Templates Announces the FDA Removal of Partial..
26/5/202316:10GLOBEMolecular Templates to Present on Phase I Dose Escalation..
15/5/202315:13GLOBEMolecular Templates, Inc. Reports First Quarter 2023..

Su Consulta Reciente

NASDAQ
MTEM
Molecular Templates
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados